Illumina Inc logo

ILMN - Illumina Inc Share Price

$324.72 -1.2  -0.4%

Last Trade - 17/01/20

Sector
Healthcare
Size
Large Cap
Market Cap £36.69bn
Enterprise Value £35.13bn
Revenue £2.66bn
Position in Universe 235th / 6416
Bullish
Bearish
Unlock ILMN Revenue
Momentum
Relative Strength (%)
1m
3m
6m
1yr
Volume Change (%)
10d / 3m
Price vs... (%)
52w High
50d MA
200d MA
Margin of Safety
Qualifying GuruScreens
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Distress
Cautious
Safe
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Graphical History

Revenue

ILMN Revenue Unlock ILMN Revenue

Net Income

ILMN Net Income Unlock ILMN Revenue

Normalised EPS

ILMN Normalised EPS Unlock ILMN Revenue

PE Ratio Range

ILMN PE Ratio Range Unlock ILMN Revenue

Dividend Yield Range

ILMN Dividend Yield Range Unlock ILMN Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2020
31st Dec 2021
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2019 /  2020
ILMN EPS Forecasts Unlock ILMN Revenue
Profile Summary

Illumina, Inc. (Illumina) is a provider of sequencing- and array-based solutions for genetic analysis. The Company operates through two segments: Core Illumina and the consolidated variable interest entities (VIEs), which include the activities of GRAIL, Inc. (GRAIL) and Helix Holdings I, LLC (Helix). Core Illumina consists of its core operations. Core Illumina's products and services serve customers in the research, clinical and applied markets, and enable the adoption of a range of genomic solutions. The Company's portfolio of integrated systems, consumables and analysis tools addresses the range of genomic complexity, price points, and throughput, enabling customers to select the solution for their research or clinical challenge. The Company provides reproductive-health solutions, including noninvasive prenatal testing (NIPT), preimplantation genetic screening and diagnosis, and neonatal and genetic health testing.

Directors
Last Annual December 30th, 2018
Last Interim September 29th, 2019
Incorporated May 16, 2000
Public Since July 28, 2000
No. of Shareholders: 147
No. of Employees: 7,300
Sector Healthcare
Industry Healthcare Equipment & Supplies
Index Nasdaq Composite , Nasdaq 100 , S&P Composite 1500 , S&P 500 , S&P 500 Health Care (sector),
Exchange NASDAQ Global Select Market
Shares in Issue 147,000,000
Free Float (0.0%)
Eligible for
ISAs
SIPPs
ILMN Share Price Performance
Share Price
Bid - Ask
Low - High
Spread
Day's Change
Avg Volume
Open - Close
Range (12m)
Beta
Latest News for ILMN
Upcoming Events for ILMN
Similar to ILMN
© Stockopedia 2020, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.